AI-generated summary
This review article examines photodynamic therapy for polypoidal choroidal vasculopathy, a retinal disease more often seen in pigmented individuals, and compares it with exudative macular degeneration. The authors report that PDT results appear promising, with only a small fraction of patients needing retreatment in the year after treatment, and that combining PDT with anti-VEGF or triple therapy was also reported as effective or promising. The article is a narrative review, so the evidence is not formally pooled.
- Who or what was studied
- Patients with polypoidal choroidal vasculopathy, a form of retinal disease more frequently encountered among pigmented individuals
- Limits stated in the abstract
- The abstract describes a narrative review without stating the number of studies or patients included, and the reported outcomes are described only qualitatively.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photodynamic therapy, Age-related macular degeneration. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.